FDA NDC Directory · JSON-LD · Markdown

NOXAFIL

NDC 0085-1328 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameposaconazole
Labeler / ManufacturerMerck Sharp & Dohme LLC
Marketing categoryNew Drug Application (innovator) · App NDA022003
Dosage form / routeSUSPENSION · ORAL
Active ingredientsPOSACONAZOLE (40 mg/mL)
Marketing started20060915
Package count1

External sources

Source: openFDA. Public-domain (CC0).